BioStem Technologies, Inc. (BSEM) stock
BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)
Close on Nov 20, 2026Market cap $11.34MP/E –Yield –
BioStem Technologies gross margin
Gross margin is gross profit as a percentage of revenue.
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 61.3% | – |
| Q2 FY2025 | Jun 30, 2025 | 93.8% | – |
See a number that looks wrong?